Molecular studies using human SCLC (hSCLC) cell lines showed that ASCL1 and NEUROD1 are required for the survival of the cells’ increased tumor-initiating capacity in xenograft assays suggesting that these factors lead to similar cellular consequences [57,58,59]. The gene discussed is ASCL1; the disease is small cell lung carcinoma.